United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2018_register executive 2018-12-11 article Rules and Regulations D09002ee1c7ddaed0 D09002ee1c7ddc156 United States Department of Defense originator org United States Government Agency or Subagency United States Office of the Secretary originator org United States Government Agency or Subagency This interim final rule implements Section 702 of the National Defense Authorization Act for Fiscal Year 2018 (NDAA FY18). The law makes significant changes to the TRICARE Pharmacy Benefits Program, specifically it: Updates co-payment requirements; authorizes a new process for encouraging use of pharmaceutical agents that provide the best clinical effectiveness by excluding coverage for particular pharmaceutical agents that provide very little or no clinical effectiveness relative to similar agents and for giving preferential status to agents that provide enhanced clinical effectiveness; and authorizes special reimbursement methods, amounts, and procedures to encourage use or high-value products and discourage use of low-value products with respect to pharmaceutical agents provided as part of medical services from authorized providers. 83 FR 63574 https://www.govinfo.gov/app/details/FR-2018-12-11/2018-26562 2018-26562 fr11de18-6 RIN 0720-AB75 5001-06-P DOD-2018-HA-0062 https://www.govinfo.gov/app/details/FR-2018-12-11/2018-26562 https://www.govinfo.gov/content/pkg/FR-2018-12-11/html/2018-26562.htm https://www.govinfo.gov/content/pkg/FR-2018-12-11/pdf/2018-26562.pdf Claims Dental Health Health Care Health Insurance Individuals with Disabilities Mental Health Mental Health Parity Military Personnel 5 p. 63574 63578 83 FR 63574 Title 32 Part 199 32 CFR Part 199 RIN 0720-AB75 TRICARE Pharmacy Benefits Program Reforms; Federal Register Vol. 83, Issue RULE 2018-26562 DEPARTMENT OF DEFENSE Office of the Secretary 2018-12-11 2019-02-11 DOD-2018-HA-0062 5001-06-P 2018-26562 Interim final rule.

This interim final rule implements Section 702 of the National Defense Authorization Act for Fiscal Year 2018 (NDAA FY18). The law makes significant changes to the TRICARE Pharmacy Benefits Program, specifically it: Updates co-payment requirements; authorizes a new process for encouraging use of pharmaceutical agents that provide the best clinical effectiveness by excluding coverage for particular pharmaceutical agents that provide very little or no clinical effectiveness relative to similar agents and for giving preferential status to agents that provide enhanced clinical effectiveness; and authorizes special reimbursement methods, amounts, and procedures to encourage use or high-value products and discourage use of low-value products with respect to pharmaceutical agents provided as part of medical services from authorized providers.

This interim final rule is effective December 11, 2018. Comments must be received by February 11, 2019. David W. Bobb, RPh, JD, Chief, Pharmacy Operations, Defense Health Agency (DHA), telephone (703) 681- 2890. Claims Dental Health Health Care Health Insurance Individuals with Disabilities Mental Health Mental Health Parity Military Personnel TRICARE Pharmacy Benefits Program Reforms , health.mil Vol. 83, no. 237 Office of the Federal Register, National Archives and Records Administration 2018-12-11 continuing daily deposited born digital 226 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2018-12-11 P0b002ee19e1a0d7f 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr11de18 https://www.govinfo.gov/app/details/FR-2018-12-11 https://www.govinfo.gov/content/pkg/FR-2018-12-11/pdf/FR-2018-12-11.pdf https://www.govinfo.gov/content/pkg/FR-2018-12-11/xml/FR-2018-12-11.xml fdlp 63559 63774 DGPO 2018-12-11 2024-05-31 FR-2018-12-11 machine generated eng FR FR-2018-12-11 83 237